[Discontinuation of oral anticoagulant therapy following fibrinolytic treatment in arterial occlusive disease].
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D003374:Coumarins / Q000627:therapeutic use; D004341:Drug Evaluation; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D013300:Streptokinase / Q000627:therapeutic use
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase
Orale Antikoagulantieneinstellung nach fibrinolytischer Therapie bei arterieller Verschlusskrankheit